Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 5 (2008), Issue 6 (June)

1. Insig2 is associated with colon tumorigenesis and inhibits Bax-mediated apoptosis.
   Int J Cancer, 123(2): 273-82. [Abstract] [Full-text]
2. Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir.
   Int J Cancer, 123(2): 476-83. [Abstract] [Full-text]
3. Massive lower gastrointestinal hemorrhage caused by a large extraluminal leiomyoma of the colon: report of a case.
   Dis Colon Rectum, 51(6): 975-8. [Abstract] [Full-text]
4. A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis.
   Dis Colon Rectum, 51(6): 897-901. [Abstract] [Full-text]
5. Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer.
   Dis Colon Rectum, 51(6): 891-6. [Abstract] [Full-text]
6. Growth inhibition of colon cancer cells by polyisoprenylated benzophenones is associated with induction of the endoplasmic reticulum response.
   Int J Cancer, 123(3): 687-94. [Abstract] [Full-text]
7. Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
   JAMA, 299(21): 2515-23. [Abstract] [Full-text]
8. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
   J Clin Invest, 118(6): 2111-20. [Abstract] [Full-text]
9. Is CD133 a marker of metastatic colon cancer stem cells?
   J Clin Invest, 118(6): 2021-4. [Abstract] [Full-text]
10. Antitumor actions of a chromone glucoside cnidimoside A isolated from Cnidium japonicum.
    Nat Med (Tokyo), 62(3): 308-13. [Abstract] [Full-text]
11. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma.
    Oncogene, 27(25): 3624-34. [Abstract] [Full-text]
12. Implementation of the scientific evidence into daily practice--example from fast-track colonic cancer surgery.
    Colorectal Dis, 10(6): 593-8. [Abstract] [Full-text]
13. High efficiency reconstitution of a human-mouse chimeric Fab of CAb-1 antibody specific to human colon cancer.
    Scand J Immunol, 68(1): 12-21. [Abstract] [Full-text]
14. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology.
    J Clin Oncol, 26(17): 2828-38. [Abstract] [Full-text]
15. Down-modulation of B cell signal transduction by ligation of mucins to CD22.
    Biochem Biophys Res Commun, 372(1): 45-50. [Abstract] [Full-text]
16. MA-NOS radical sigmoidectomy: report of a transvaginal resection in the human.
    Surg Endosc, 22(7): 1717-23. [Abstract] [Full-text]
17. Identification of further elongation and branching of dimeric type 1 chain on lactosylceramides from colonic adenocarcinoma by tandem mass spectrometry sequencing analyses.
    J Biol Chem, 283(24): 16455-68. [Abstract] [Full-text]
18. Activated K-RAS increases polyamine uptake in human colon cancer cells through modulation of caveolar endocytosis.
    Mol Carcinog, 47(7): 538-53. [Abstract] [Full-text]
19. Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G.
    Mol Carcinog, 47(7): 519-25. [Abstract] [Full-text]
20. Role for epithelial dysregulation in early-onset colitis-associated colon cancer in Gi2-alpha-/- mice.
    Inflamm Bowel Dis, 14(7): 898-907. [Abstract] [Full-text]
21. Intrinsically disordered human C/EBP homologous protein regulates biological activity of colon cancer cells during calcium stress.
    J Mol Biol, 380(2): 313-26. [Abstract] [Full-text]
22. Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours.
    Hum Mol Genet, 17(13): 1978-87. [Abstract] [Full-text]
23. A study of lymph node ratio as a prognostic marker in colon cancer.
    Eur J Surg Oncol, 34(7): 771-5. [Abstract] [Full-text]
24. Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis.
    Gut, 57(7): 931-40. [Abstract] [Full-text]
25. Polyamine catabolism in colorectal cancer cells following treatment with oxaliplatin, 5-fluorouracil and N1, N11 diethylnorspermine.
    Cancer Chemother Pharmacol, 62(3): 517-27. [Abstract] [Full-text]
26. Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched.
    RNA, 14(7): 1424-32. [Abstract] [Full-text]
27. Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells.
    Exp Cell Res, 314(11): 2212-23. [Abstract] [Full-text]
28. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice.
    Int J Cancer, 123(4): 951-7. [Abstract] [Full-text]
29. Differential impact of TGF-beta and EGF on fibroblast differentiation and invasion reciprocally promotes colon cancer cell invasion.
    Cancer Lett, 266(2): 263-74. [Abstract] [Full-text]
30. Signaling and regulatory mechanisms of integrin alphavbeta6 on the apoptosis of colon cancer cells.
    Cancer Lett, 266(2): 209-15. [Abstract] [Full-text]
31. Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells.
    Biochem Biophys Res Commun, 372(4): 845-9. [Abstract] [Full-text]
32. The high affinity peroxisome proliferator-activated receptor-gamma agonist RS5444 inhibits both initiation and progression of colon tumors in azoxymethane-treated mice.
    Int J Cancer, 123(5): 991-7. [Abstract] [Full-text]
33. Prospective weight change and colon cancer risk in male US health professionals.
    Int J Cancer, 123(5): 1160-5. [Abstract] [Full-text]
34. Increased risk of colon cancer after external radiation therapy for prostate cancer.
    Int J Cancer, 123(5): 1141-5. [Abstract] [Full-text]
35. The long-term results of a randomized clinical trial of laparoscopy-assisted versus open surgery for colon cancer.
    Ann Surg, 248(1): 1-7. [Abstract] [Full-text]
36. Linoleic-acid-induced growth suppression induces quiescent cancer cell nests in nude mice.
    Pathobiology, 75(4): 226-32. [Abstract] [Full-text]
37. Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model.
    Am J Pathol, 173(1): 205-16. [Abstract] [Full-text]
38. Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.
    Biochem Pharmacol, 76(2): 198-207. [Abstract] [Full-text]
39. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Biochem Pharmacol, 76(2): 179-87. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.